Skip to content

Metabolism Associated With Abdominal Fat Mass Distribution

Metabolism Associated With Abdominal Fat Mass Distribution

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01726647
Enrollment
40
Registered
2012-11-15
Start date
2008-09-30
Completion date
2012-04-30
Last updated
2012-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obese

Keywords

obese women, fat mass distribution, Metabolomic profiles

Brief summary

Objectives: The primary objective of this clinical trial is to characterize metabolic signatures associated with abdominal fat distribution in 40 women with different BMI 29-40 and different abdominal distribution of fat (visceral vs. sub-cutaneous fat). No intervention with a product is planned. The subjects will be given one high fat meal with commercial products (eggs, milk, cream, bread, fruits, cheese and cheese) on one test day to test the post-prandial metabolic response.

Interventions

None listed

Sponsors

University of Lausanne Hospitals
CollaboratorOTHER
Société des Produits Nestlé (SPN)
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI 29-40 kg/m2 * Aged 25-45

Exclusion criteria

* Diagnosed metabolic disorder such as Diabetes type 1 and 2, cardiovascular disease, metabolic syndrome * Pregnancy * Any pathology (infectious or other) having required an antibiotic therapy within 1 month prior to the beginning of the study. * Any therapy (contraception apart) within the run-in period of one week before the test day. * Subject who cannot be expected to comply with treatments and measures. * Subject who is affected by any specific eating disorder * Currently participating or having participated in another clinical trial during the last 3 months prior to the beginning of this study. * Subjects having recently undergone a weight loss of more than 3 kilos during the last 3 months

Design outcomes

Primary

MeasureTime frameDescription
Metabolic plasma, urine and faeces profiles as a function of fat mass distributionChanges from baseline in metabolic profiles at one day following fat meal intakeMetabolic profiles of plasma, urine and feces samples are obtained by Nuclear Magnetic Resonance spectroscopy and Mass Spectrometry. Fat mass distribution is assessed using CT scan and DXA (Dual X-Ray Energy Absorptiometry).

Secondary

MeasureTime frameDescription
Insulin sensitivityMeasured on the day before the fat meal intakeInsulin sensitivity is measured by oral glucose tolerance test
Basal Energy ExpenditureBasal Energy Expenditure is measured on the day preceding the fat meal intakeBasal Energy Expenditure is measured by indirect calorimetry

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026